Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Abstract Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tole...

Full description

Bibliographic Details
Main Author:	Nicholas J. White
Format:	Article
Language:	English
Published:	BMC 2019-10-01
Series:	Malaria Journal
Online Access:	http://link.springer.com/article/10.1186/s12936-019-2955-z

Similar Items

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
by: Sanjeev Krishna
Published: (2019-10-01)

Artemisinin-Based Combination Anti-malarials Do Not Enhance Anti-melanoma Activity of Artemisinin-Monotherapy
by: Jacobs, Suesan, et al.
Published: (2013)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment
by: Ye Xiong, et al.
Published: (2021-08-01)

Editorial to the Feature article “Artemisinin anti-malarial drugs in China”
by: Ao Zhang
Published: (2016-03-01)

More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration
by: Bing-Wen Lu, et al.
Published: (2019-01-01)

Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
by: John H Amuasi, et al.
Published: (2012-01-01)

Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
by: Amber Kunkel, et al.
Published: (2021-03-01)

Modulating effects of plasma containing anti-malarial antibodies on <it>in vitro </it>anti-malarial drug susceptibility in <it>Plasmodium falciparum</it>
by: Udomsangpetch Rachanee, et al.
Published: (2010-11-01)

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01)

Flavonoid Versus Artemisinin Anti-malarial Activity in Artemisia annua Whole-Leaf Extracts
by: Tomasz Czechowski, et al.
Published: (2019-07-01)

Synthesis and anti-malarial activity of ethylene glycol oligomeric ethers of artemisinin / Minette Steyn
by: Steyn, Minette
Published: (2012)

Synthesis and anti-malarial activity of ethylene glycol oligomeric ethers of artemisinin / Minette Steyn
by: Steyn, Minette
Published: (2012)

The role of anti-malarial drugs in eliminating malaria
by: White Nicholas J
Published: (2008-12-01)

Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)
by: Ringsted Frank M, et al.
Published: (2011-08-01)

Malarial pathogenesis and interventions in Kelch mediated Artemisinin resistance in Plasmodium falciparum
by: Pittala, Keerthana
Published: (2019)

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries
by: ACTwatch Group, et al.
Published: (2017-05-01)

Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
by: Van Erps Jan, et al.
Published: (2011-03-01)

Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.
by: Juan Wang, et al.
Published: (2010-01-01)

Anti‐malarial drug effects on parasite dynamics in vivax malaria
by: Nicholas J. White
Published: (2021-03-01)

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
by: Krongkan Srimuang, et al.
Published: (2016-11-01)

<it>In vitro</it> interaction of artemisinin derivatives or the fully synthetic peroxidic anti-malarial OZ277 with thapsigargin in <it>Plasmodium falciparum</it> strains
by: Abiodun Oyindamola O, et al.
Published: (2013-01-01)

Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?
by: Barnes Karen I, et al.
Published: (2008-09-01)

Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
by: Johanna M Porter-Kelley, et al.
Published: (2010-08-01)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
by: David Dolivo, et al.
Published: (2021-02-01)

Correction to: Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
by: Krongkan Srimuang, et al.
Published: (2018-09-01)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
by: Dao Ngoc Hien Tam, et al.
Published: (2020-08-01)

Extent of inappropriate prescription of artemisinin and anti-malarial injections to febrile outpatients, a cross-sectional analytic survey in the Greater Accra region, Ghana
by: Harriet Affran Bonful, et al.
Published: (2019-09-01)

Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty
by: McKenzie F Ellis, et al.
Published: (2010-07-01)

Towards optimal design of anti-malarial pharmacokinetic studies
by: White Nicholas J, et al.
Published: (2009-08-01)

Modeling response and delayance to parasite clearance time to artemisinin combination therapies(ACT)
by: Nji, Akindeh Mbuh
Published: (2013)

The consequences of artemisinin resistance in <it>falciparum</it> malaria
by: White Nicholas J
Published: (2012-10-01)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia
by: Socheat Doung, et al.
Published: (2008-05-01)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience
by: Socheat Duong, et al.
Published: (2008-05-01)

Molecular markers in <it>plasmodium falciparum </it>linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy
by: Amor Aranzazu, et al.
Published: (2012-03-01)

Computational analysis of binding between malarial dihydrofolate reductases and anti-folates
by: White Nicholas J, et al.
Published: (2010-03-01)

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
by: Lee Sue J, et al.
Published: (2009-11-01)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
by: Paulina Tindana, et al.
Published: (2021-02-01)

ANTI-MALARIAL DRUG RESISTANCE
by: Yenni Yusuf
Published: (2014-05-01)

Poisoning by anti-malarial drugs
by: David Tibbutt
Published: (2013-08-01)